DUBLIN, Jan 15 (Reuters) - The European Medicines Agency
(EMA) hopes Johnson & Johnson will seek regulatory
approval for its COVID-19 vaccine in February, its executive
director said on Friday.
"We hope it is to come in February, but whether I could
confirm that that's the case, I'm afraid I'm not in a position
to do so," Emer Cooke told a virtual event.
A top EU lawmaker this week said the U.S. healthcare company
was likely to seek EU regulatory approval next month.
Europe's drugs regulator has so far recommended the
Pfizer-BioNtech, and Moderna
vaccines and is reviewing another by AstraZeneca under
an accelerated timeline.
Cooke added that the EMA has not yet had applications for
the Russian or Chinese vaccines, but is in discussions with the
Russian vaccine developer.
(Reporting by Padraic Halpin; Editing by Jan Harvey)